id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
APHIS-2012-0017-0003,APHIS,APHIS-2012-0017,"Risk Analysis [Confidential Business Information Redacted] Feline lnterleukin-2 lmmunomodulator, Live Canarypox Vector, Product Code 9401.RO Merial Ltd.",Supporting & Related Material,Risk Assessment,2012-04-13T04:00:00Z,2012,4,,,2012-04-13T13:24:20Z,,0,0,0900006480fd805a
APHIS-2012-0017-0002,APHIS,APHIS-2012-0017,"Environmental Assessment For Field Testing of a Feline Interleukin-2 Immunomodulator, Live Canarypox Vector",Supporting & Related Material,Environmental Assessment,2012-04-13T04:00:00Z,2012,4,,,2012-04-13T13:24:20Z,,0,0,0900006480fd7fcb
APHIS-2012-0017-0001,APHIS,APHIS-2012-0017,"Availability of an Environmental Assessments for Field Testing Feline Interleukin-2 Immunomodulator, Live Canarypox Vector",Notice,Availability of Environmental Assessment,2012-04-13T04:00:00Z,2012,4,2012-04-13T04:00:00Z,2012-05-15T03:59:59Z,2012-04-13T13:23:34Z,2012-08912,0,0,0900006480feef89